Biopharmaceutical companies developing cancer treatments need to restart the clinical trials shut down or delayed during the early stages of the coronavirus pandemic. Some are holding back, however, due to a lack of confidence that sufficient eligible patients can be recruited and enrolled in the trials. Recruiting patients into a clinical trial was challenging before COVID-19 hit, and it has only become exponentially more difficult. Sponsors also know many patients have been putting off
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Walgreens Rolls Out Mobile Clinics to Bring COVID-19 Vaccines to Underserved Communities in Chicago
What You Should Know:
- Walgreens will activate multiple mobile clinics in Chicago. The traveling mobile clinics will focus on bringing COVID-19 vaccines directly to underserved communities and those with barriers to accessing the vaccine. Over the next two months, additional mobile clinics will make stops in a number of locations across the country.
- Individuals will be able to walk up to a mobile clinic and receive a vaccination at that time from a Walgreens pharmacy team member.
Read More
DoD, Duke, John Hopkins, HJF, physIQ Launch 18-Month COVID-19 Clinical Trial Study
What You Should Know:
- Today, PhysIQ Inc. announced its partnership with Johns Hopkins University, Duke University and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), to support a clinical trial to evaluate products for early treatment and post-exposure treatment of COVID-19. The 18-month study will assess disease progression and provide early indication of infection. This DOD-funded initiative will assess the role of continuous biosensor
Read More
Phenomix Inks Licensing Deal with Mayo Clinic for Obesity Phenotype Blood Test
What You Should Know:
- Today, Phenomix Sciences announced the company has signed an exclusive technology licensing agreement with Mayo Clinic for a novel blood test that accurately predicts obesity phenotypes.
- The multi-level “omics” MyPhenome™ test leverages technology developed at Mayo Clinic to analyze genomics, metabolomics and hormone levels. Its AI-driven algorithmic solution identifies four specific obesity phenotypes to give doctors the ability to
Read More
CVS Health Launches Employer-Based COVID-19 Vaccination Program
What You Should Know:
Today, CVS Health announced it recently began administering COVID-19 vaccines at employer-based vaccination clinics through Return Ready, the company’s comprehensive COVID-19 solution that helps employers return and maintain healthy workforces.
- With vaccine hesitancy on the rise, federal and state governments are looking to partners, like employers and CVS Health, to help by making vaccines more convenient to access and enhancing public education
Read More
Carevive, COS Ink Partnership to Improve Cancer Care with RWE
What You Should Know:
- Carevive and Clinical Outcome Solutions (COS) announced a new partnership to improve the cancer patient experience using RWE and RWD. The partnership will leverage Carevive’s innovative digital oncology platform to capture the patient experience, and COS’ deep experience in analyzing data, ultimately providing valuable insights for life science companies and regulators alike.
- The Carevive platform PROmpt enables cancer care teams to monitor and manage
Read More
Abbott Launches New AI-Powered Coronary Imaging Platform in Europe
What You Should Know:
- Abbott announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe. This first-of-its-kind imaging software merges optical coherence tomography (OCT) – an imaging tool that provides physicians a comprehensive view inside an artery or blood vessel – with the power of artificial intelligence (AI) for enhanced visualization.
- The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure
Read More
Health2047 Spins Out SiteBridge Research Launches to Improve Clinical Trial Access for Small and Community Physician Practices
What You Should Know:
- Health2047, the innovation arm of the American Medical Association, today announced the spinout of a new company, SiteBridge Research, that offers a more accessible way for a broader set of physicians and their patients to participate in clinical research.
- SiteBridge Research creates a network of independent, small practice physicians to gather data from a broader, more inclusive patient population and, ultimately, create more widely applicable clinical
Read More
Streamlining Biospecimen Procurement: Avoid These 8 Common R&D Mistakes
Long before a clinician administers a drug or runs a new test, there is the arduous R&D cycle. Unfortunately, it’s rarely as streamlined as the one that just delivered COVID-19 vaccines in record-shattering time.
For most Americans, vaccines and drugs seem to spring wholly formed from clinical trials, which are becoming part of America’s everyday conversation. But before any vaccine or therapy hits the market, the less-visible pre-clinical research and development must be performed – from
Read More
Syneos, Medable Team Up to Bring Decentralized Clinical Trials to Patients
What You Should Know:
- Syneos Health, a fully integrated biopharmaceutical solutions organization, and Medable, a cloud platform for patient-centered drug development, announced a strategic partnership to bring clinical trials closer to the patient.
- The partnership will deliver new decentralized capabilities to Syneos Health with the aim of increasing clinical trial diversity, while improving patient access and experiences to transform biopharmaceutical product development.
- As part
Read More
